Navigator

      Support By : Li-lab

Drug-Pathway
DRUGs and PATHWAYs
PATHWAY_NAME REACTOME_ID KEGG_ID DRUG_NAME PUBCHEM_CID Datasource
Axon guidance R-HSA-422475 map04360 nisoxetine 4500 drug-path
Asthma R-HSA-444620 map05310 nisoxetine 4500 drug-path
Allograft rejection R-HSA-9679028 map05330 nisoxetine 4500 drug-path
Colorectal cancer R-HSA-4791275 map05210 nisoxetine 4500 drug-path
Type I diabetes mellitus R-HSA-5683209 map04940 nisoxetine 4500 drug-path
Neuroactive ligand-receptor interaction R-HSA-5632681 map04080 nisoxetine 4500 drug-path
Huntington's disease R-HSA-1643685 0 nisoxetine 4500 drug-path
Olfactory transduction R-HSA-9751605 map04740 bufexamac 2466 drug-path
Cell adhesion molecules (CAMs) R-HSA-1031690 0 bufexamac 2466 drug-path
Type II diabetes mellitus R-HSA-2127377 map04930 bufexamac 2466 drug-path
Graft-versus-host disease R-HSA-1643685 map05332 bufexamac 2466 drug-path
Neuroactive ligand-receptor interaction R-HSA-5632681 map04080 bufexamac 2466 drug-path
Shigellosis 0 map05131 bufexamac 2466 drug-path
Pathogenic Escherichia coli infection R-HSA-9609646 map05130 bufexamac 2466 drug-path
Systemic lupus erythematosus R-HSA-977105 map05322 bufexamac 2466 drug-path
Asthma R-HSA-444620 map05310 bufexamac 2466 drug-path
RNA polymerase R-HSA-73864 map03020 bufexamac 2466 drug-path
Calcium signaling pathway R-HSA-381753 map04020 bufexamac 2466 drug-path
Allograft rejection R-HSA-9679028 map05330 bufexamac 2466 drug-path
Type I diabetes mellitus R-HSA-5683209 map04940 bufexamac 2466 drug-path